Added 2 days ago Drug news

Phase III ATTAIN trial data of Vibativ in hospital-acquired pneumonia published in Infectious Diseases and Therapy.- Cumberland Pharma

Cumberland Pharmaceuticals has announced a new publication in Infectious Diseases and Therapy, showing numerically superior cure rates of Vibativ (telavancin)...

Added 12 days ago Drug news

Shionogi reports positive results from cefiderocol phase III study in adults with pneumonia caused by gram-negative pathogens.

Shionogi & Co., Ltd. announced results from APEKS-NP, an international, double-blind, randomized Phase III clinical trial evaluating the efficacy and...

Added 14 days ago Drug news

FDA accepts two applications for Dificid to treat children aged six months up to 18 years with Clostridium difficile infections.- Merck Inc.

Merck Inc.,has announced the FDA has accepted for review a New Drug Application (NDA) for Dificid (fidaxomicin) for oral suspension,...

Surgical site infections: prevention and treatment

This guideline covers preventing and treating surgical site infections in adults, young people and children who are having a surgical procedure involving a cut through the skin.

Added 10 years ago

Guidelines on Urological Infections

The European Association of Urology (EAU) Urological Infections Guidelines Panel has compiled these clinical guidelines to provide medical professionals with evidence-based information and recommendations for...

Added 3 years ago

The Prevention of Early-onset Neonatal Group B Streptococcal Disease

The purpose of this guideline is to provide guidance for obstetricians, midwives and neonatologists on the prevention of early-onset (less than 7 days of age) neonatal group B streptococcal (EOGBS) disease...

Added 7 years ago

Pseudomonas aeruginosa in cystic fibrosis patients with c.1652G›A (G551D)-CFTR treated with ivacaftor-Changes in microbiological parameters.

The CFTR potentiator, ivacaftor (IVA), has been widely used in the treatment of cystic fibrosis (CF) patients with the G551D mutation. To date, there has been limited information on the microbiological status...

Added 1 year ago

Early goal-directed therapy in the treatment of severe sepsis and septic shock.

Goal-directed therapy has been used for severe sepsis and septic shock in the intensive care unit.

Added 2 years ago

Early, goal-directed therapy for septic shock – a patient-level meta-analysis.

After a single-center trial and observational studies suggesting that early, goal-directed therapy (EGDT) reduced mortality from septicshock, three multicenter trials (ProCESS, ARISE, and ProMISe) showed no benefit.

Added 2 years ago